ClinicalTrials.Veeva

Menu

Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term

M

Mahidol University

Status and phase

Terminated
Phase 4

Conditions

Perineal Wound Infection

Treatments

Drug: Placebo
Drug: Amoxicillin

Study type

Interventional

Funder types

Other

Identifiers

NCT02131818
SI-OBG-CEU-01-2014

Details and patient eligibility

About

The purpose of this study is to determine amoxicillin is effective in the prevention of wound infection in normal labor.

Full description

When the pregnant women is admitted due to first stage of labor , the investigator will inform the patients. If the patients give consent, the patient's data will be collect in case record form. the patients will be swab at posterior fornix and around anus to collect specimen and send to microbiology lab before per vaginal examination. After the patients finish in labor, perineal wound will be swab to collect specimen and send to microbiology lab. Then the patients are randomized in two group, the first one will receive amoxicillin and the second one will receive placebo. During admission the patients will be exam by investigator every day. After the patients are discharge, the follow up will be appoint on 6 weeks later. The infant will be swab at rectum to collect specimen and send to microbiology lab when the patient's discharge day. Every specimen will be culture for bacteria and perform antimicrobial susceptibility test for amoxicillin.

Enrollment

5 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Term pregnancy
  • Normal labor

Exclusion criteria

  • Penicillin allergy
  • Previous history antibiotic using within 2 weeks
  • Patients cannot take oral medication
  • Patients have underlying disease eg. diabetes mellitus, hypertension, HIV infection
  • Premature rupture of membranes

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

5 participants in 2 patient groups, including a placebo group

Amoxicillin
Experimental group
Description:
The patient will be received amoxicillin 500 mg 2 capsules orally bid pc for 5 days
Treatment:
Drug: Amoxicillin
Placebo
Placebo Comparator group
Description:
The patient will be received placebo 2 capsules orally bid pc for 5 days
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems